ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,615.87
0.64%
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs Yen
157.405
0.00%
Brent Oil
82.17
-0.13%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Napro Biotherapeutics (MM) (NPRO)

  7. Napro Biotherapeutics (MM) (NPRO) ニュース

NPRO

Napro Biotherapeutics (NPRO)

Napro Biotherapeutics (MM)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:NPRO
日付受信時刻ニュースソース見出しコード企業名
2004/05/0506 : 30PR Newswire (US)NaPro Changes Name to Tapestry PharmaceuticalsNASDAQ:NPRO
2004/04/2722 : 30PR Newswire (US)NaPro Announces Formation of Oncology Scientific Advisory BoardNASDAQ:NPRONapro Biotherapeutics (MM)
2004/04/2222 : 30PR Newswire (US)NaPro Announces Formation of Chemistry Advisory BoardNASDAQ:NPRONapro Biotherapeutics (MM)
2004/03/2622 : 00PR Newswire (US)NaPro Announces the Sale of Two Million Common SharesNASDAQ:NPRONapro Biotherapeutics (MM)
2004/03/2302 : 01PR Newswire (US)NaPro BioTherapeutics to Present at the Wells Fargo Securities Health Care ConferenceNASDAQ:NPRONapro Biotherapeutics (MM)
2004/03/1123 : 37PR Newswire (US)NaPro Reports Fourth Quarter and Full-Year 2003 ResultsNASDAQ:NPRONapro Biotherapeutics (MM)
2004/03/1023 : 35PR Newswire (US)Stephen K. Carter, M.D. Joins NaPro Board of DirectorsNASDAQ:NPRONapro Biotherapeutics (MM)
2004/01/1222 : 30PR Newswire (US)NaPro Announces Additions to Scientific Advisory BoardNASDAQ:NPRONapro Biotherapeutics (MM)
2003/12/2422 : 30PR Newswire (US)Court Rules in Favor of NaPro in Mylan Patent Infringement CaseNASDAQ:NPRONapro Biotherapeutics (MM)
2003/12/2306 : 01PR Newswire (US)NaPro BioTherapeutics Announces the Appointment of Anne Bailey as Vice President and General Manager, Genomics DivisionNASDAQ:NPRONapro Biotherapeutics (MM)
2003/12/1307 : 34PR Newswire (US)NaPro Completes Sale of Worldwide Paclitaxel Business to Mayne PharmaNASDAQ:NPRONapro Biotherapeutics (MM)
2003/12/0422 : 52PR Newswire (US)NaPro Awarded Phase I SBIR Grant for Research on Muscular DystrophyNASDAQ:NPRONapro Biotherapeutics (MM)
2003/11/1922 : 42PR Newswire (US)NaPro Unveils Targeted Therapeutic Platform for Lung, Breast, and Other Cancers at AACR-NCI-EORTC ConferenceNASDAQ:NPRONapro Biotherapeutics (MM)
2003/11/1322 : 28PR Newswire (US)NaPro Reports Third Quarter 2003 ResultsNASDAQ:NPRONapro Biotherapeutics (MM)
2003/11/1222 : 30PR Newswire (US)December 1 Trial Date Set in NaPro vs Mylan Patent Infringement CaseNASDAQ:NPRONapro Biotherapeutics (MM)
2003/11/1021 : 45PR Newswire (US)Reminder - NaPro BioTherapeutics to Present at The Wall Street Analyst Forum On November 10NASDAQ:NPRONapro Biotherapeutics (MM)
2003/11/0800 : 23PR Newswire (US)NaPro BioTherapeutics to Present at The Wall Street Analyst Forum On November 10NASDAQ:NPRONapro Biotherapeutics (MM)
 Showing the most relevant articles for your search:NASDAQ:NPRO

最近閲覧した銘柄

CCOM
US100
US Tech 100
AMEX
XLF
Financial Select Sector
NYSE
XOM
Exxon Mobil
AMEX
XLV
Health Care Select Sector
NYSE
KO
Coca Cola
NYSE
JPM
JP Morgan Chase
NYSE
NKE
Nike
NASDAQ
AMZN
Amazon.com
SPI
SP500
S&P 500
NYSE
MCD
McDonalds
NYSE
BAC
Bank of America
PM
XAUUSD
Gold vs US Dollar
FX
USDGBP
US Dollar vs Sterling
CCOM
SILVER
SILVER
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有